Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases (Q3696479)

From EU Knowledge Graph
Revision as of 17:06, 6 December 2021 by DG Regio (talk | contribs) (‎Changed label, description and/or aliases in nl, and other parts: Adding Dutch translations)
Jump to navigation Jump to search
Project Q3696479 in France
Language Label Description Also known as
English
Development of S-nitrosothiol nanoparticles as a preventive treatment of chronic inflammatory bowel diseases
Project Q3696479 in France

    Statements

    0 references
    15,500.0 Euro
    0 references
    32,000.0 Euro
    0 references
    48.44 percent
    0 references
    1 September 2015
    0 references
    31 December 2016
    0 references
    Université de Lorraine
    0 references
    0 references
    Mise en place d’un traitement chronique préventif, basé sur l’administration orale de S-nitrosothiols (RSNO (French)
    0 references
    Introduction of chronic preventive treatment based on oral administration of S-nitrosothiols (RSNO) (English)
    22 November 2021
    0 references
    Einführung einer chronischen präventiven Behandlung auf der Grundlage der oralen Verabreichung von S-Nitrosothiols (RSNO) (German)
    1 December 2021
    0 references
    Invoering van chronische preventieve behandeling op basis van orale toediening van S-nitrosothiols (RSNO) (Dutch)
    6 December 2021
    0 references

    Identifiers

    LO0006484
    0 references